- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Chugai Pharmaceutical Co Ltd ADR (CHGCY)Assess today's live Chugai Pharmaceutical Co Ltd ADR (CHGCY) share price, performance and insights using our live OTC Markets: CHGCY stock exchange data.
Analyse the historical data and Chugai Pharmaceutical Co Ltd ADR share price performance charts on this page. Our technical summary section provides analysis on Chugai Pharma ADR share price buy/sell indicators using real-time data (or discuss the Chugai Pharma ADR (CHGCY) stock price today with other investors in the Chugai Pharma ADR OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC CHGCY share price (ISIN: US1712691039) to enhance your trading decisions with our free investment tools and resources.
What Is the Chugai Pharmaceutical Co Ltd ADR Share Price Today?
The Chugai Pharma ADR share price today is 22.06.
What Is the Stock Symbol for Chugai Pharmaceutical Co Ltd ADR
The stock symbol (or 'ticker') for Chugai Pharmaceutical Co Ltd ADR is "CHGCY."
What Stock Exchange Does Chugai Pharmaceutical Co Ltd ADR Trade On?
Chugai Pharmaceutical Co Ltd ADR is listed and trades on the OTC Markets stock exchange.
Is Chugai Pharmaceutical Co Ltd ADR a Good Stock to Buy?
Determining whether Chugai Pharmaceutical Co Ltd ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Chugai Pharmaceutical Co Ltd ADR share price performance charts on this page. Our technical summary section provides analysis on Chugai Pharma ADR share price buy/sell indicators using real-time data (or discuss the Chugai Pharma ADR (CHGCY) stock price today with other investors in the Chugai Pharma ADR OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC CHGCY share price (ISIN: US1712691039) to enhance your trading decisions with our free investment tools and resources.
What Is the Chugai Pharmaceutical Co Ltd ADR Share Price Today?
The Chugai Pharma ADR share price today is 22.06.
What Is the Stock Symbol for Chugai Pharmaceutical Co Ltd ADR
The stock symbol (or 'ticker') for Chugai Pharmaceutical Co Ltd ADR is "CHGCY."
What Stock Exchange Does Chugai Pharmaceutical Co Ltd ADR Trade On?
Chugai Pharmaceutical Co Ltd ADR is listed and trades on the OTC Markets stock exchange.
Is Chugai Pharmaceutical Co Ltd ADR a Good Stock to Buy?
Determining whether Chugai Pharmaceutical Co Ltd ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
22.06
+0.06(+0.25%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.45
22.38
52 wk Range
14.52
26.00
CHGCY Scorecard
Full Analysis
Trading at a high P/E ratio relative to near-term earnings growth
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.4522.38
52 wk Range
14.5226.00
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockCHGCY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has maintained dividend payments for 33 consecutive years
Chugai Pharma ADR Company Profile
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.
Compare CHGCY to Peers and Sector
Metrics to compare | CHGCY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCHGCYPeersSector | |
|---|---|---|---|---|
P/E Ratio | 28.1x | 21.7x | −0.7x | |
PEG Ratio | 1.88 | −0.37 | 0.00 | |
Price/Book | 6.0x | 1.6x | 2.6x | |
Price / LTM Sales | 9.5x | 1.9x | 3.2x | |
Upside (Analyst Target) | - | 17.2% | 44.5% | |
Fair Value Upside | Unlock | 13.7% | 6.6% | Unlock |
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 235.18
Dividend Yield
-
Annualised payout
-
5-Years Growth
-
Growth Streak
People Also Watch
FAQ
What Is the Chugai Pharma ADR (CHGCY) Stock Price Today?
The Chugai Pharma ADR stock price today is 22.06
What Stock Exchange Does Chugai Pharma ADR Trade On?
Chugai Pharma ADR is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Chugai Pharma ADR?
The stock symbol for Chugai Pharma ADR is "CHGCY."
What Is the Chugai Pharma ADR Market Cap?
As of today, Chugai Pharma ADR market cap is 72.74B.
What is Chugai Pharma ADR Earnings Per Share?
The Chugai Pharma ADR EPS is 235.18.
From a Technical Analysis Perspective, Is CHGCY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.